Danske Bank’s AEON Biopharma AEON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$0 Hold
1
– – ﹤0.01% 1166
2026
Q2
$1 Hold
1
– – ﹤0.01% 1130
2026
Q1
$1 Hold
1
– – ﹤0.01% 1155
2025
Q4
$1 Hold
1
– – ﹤0.01% 1544
2025
Q3
$1 Hold
1
– – ﹤0.01% 1476
2025
Q2
$1 Hold
1
– – ﹤0.01% 1506
2025
Q1
$1 Buy
+1
New +$7 ﹤0.01% 1352

Other funds holding AEON

Danske Bank's AEON Position: Q3 2026 in Review

Danske Bank held its AEON Biopharma (AEON) position steady in Q3 2026 at 1 share worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1166.

Danske Bank first reported a position in AEON in Q1 2025 and has held it in 7 quarters since. The position peaked at $1 in Q2 2026. 28 funds tracked by Wall St. Rank hold AEON as of Q3 2026.

  • Danske Bank held 1 share of AEON Biopharma worth $0 as of Q3 2026.
  • Danske Bank left its AEON Biopharma share count unchanged in Q3 2026.
  • AEON Biopharma made up ﹤0.01% of Danske Bank's portfolio in Q3 2026, its #1166 holding.
  • Danske Bank first reported a position in AEON Biopharma in Q1 2025 and has held it in 7 quarters since.
  • Danske Bank's AEON Biopharma position peaked at $1 in Q2 2026.
  • 28 funds tracked by Wall St. Rank held AEON Biopharma as of Q3 2026.

Based on Danske Bank's 13F filing for Q3 2026, filed 9 Nov 2026.